FPS
FLGT icon

Fieldpoint Private Securities’s Fulgent Genetics FLGT Stock Holding History

Fieldpoint Private Securities’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2K Sell
35
-85
-71% -$4.67K ﹤0.01% 1165
2022
Q1 		$7K Buy
120
+90
+300% +$5.93K ﹤0.01% 1182
2021
Q4 		$3K Sell
30
-20
-40% -$1.76K ﹤0.01% 1392
2021
Q3 		$4K Sell
50
-15
-23% -$1.36K ﹤0.01% 1308
2021
Q2 		$6K Buy
65
+50
+333% +$3.99K ﹤0.01% 1154
2021
Q1 		$1K Buy
+15
New +$1.55K ﹤0.01% 1468

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldpoint Private Securities's FLGT Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Fulgent Genetics (FLGT) stake by 71% in Q2 2022, selling an estimated $4.67K and leaving 35 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Fieldpoint Private Securities first reported a position in FLGT in Q1 2021 and has held it in 6 quarters since. The position peaked at $7K in Q1 2022. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Fieldpoint Private Securities held 35 shares of Fulgent Genetics worth $2K as of Q2 2022.
  • Fieldpoint Private Securities sold 85 Fulgent Genetics shares in Q2 2022, an estimated $4.67K.
  • Fulgent Genetics made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1165 holding.
  • Fieldpoint Private Securities first reported a position in Fulgent Genetics in Q1 2021 and has held it in 6 quarters since.
  • Fieldpoint Private Securities's Fulgent Genetics position peaked at $7K in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.